title: Primary cutaneous aspergillosis in a patient with systemic lupus erythematosus.
authors.forename: Yuchong
authors.initials: Y
authors.lastname: Chen
authors.forename: Wanqing
authors.initials: W
authors.lastname: Liao
authors.forename: Hai
authors.initials: H
authors.lastname: Wen
authors.forename: Jianghan
authors.initials: J
authors.lastname: Chen
authors.forename: Julin
authors.initials: J
authors.lastname: Gu
mesh_terms: D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000935:Antifungal Agents / Q000008:administration & dosage; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D017964:Itraconazole / Q000008:administration & dosage; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D012867:Skin / Q000187:drug effects / Q000382:microbiology; D012883:Skin Ulcer / Q000150:complications / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery
chemical_list: D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D017964:Itraconazole; D011241:Prednisone